Better Outcomes, Lower Costs
Study: Readmission Rate Was 48% Lower When Using MedActionPlan
By helping patients avoid medication errors and increasing adherence, MedActionPlan can help reduce readmission rates.
A study conducted by Sharp HealthCare and Touro University California College of Pharmacy examined the impact of a Continuum of Care Network (CCN) led by a Continuum of Care Resident Pharmacist on 30-day readmissions of heart failure patients as well as compliance with a key process of care measure, discharge instructions.
MedActionPlan schedules became one of the key interventions by the pharmacist, along with discharge counseling and resolving medication reconciliation problems. This study showed a 48% reduction in 30-day readmissions.
Another finding of the study was that after implementation of the CCN with MedActionPlan, Heart Failure core measure 1 compliance rates improved from the 80th percentile to the 90th percentile.
The impact of a Continuum of Care Resident Pharmacist on heart failure readmissions and discharge instructions at a community hospital
Julie T Truong and Andrea C Backes
Study: MedActionPlan Helped Decrease Length of Stay 56%
The United Network for Organ Sharing (UNOS) and the Centers for Medicare and Medicaid Services (CMS) require transplant centers to document the participation of a pharmacist on interdisciplinary transplant teams in order to meet accreditation standards.
Providence Sacred Heart Medical Center & Children’s Hospital (PSHMC), where about 50 kidney transplants are performed every year, conducted a retrospective analysis examining the inclusion of pharmacists on the hospital’s interdisciplinary kidney transplant team.
The analysis found that reorganizing patient education, including adoption of MedActionPlan as the standard medication list, was among the most significant contributions by the pharmacists.
The 56% reduction in lengths of stay was estimated to save $279,180 annually.
Changing transplant recipient education and inpatient transplant pharmacy practices: A single-center perspective
Angela Q. Maldonado, Douglas L. Weeks, Amanda N. Bitterman, Jo Ann McCleary, Todd C. Seiger, Richard W. Carson, Patrick K. Tabon, Angela L. Goroski, and Okechukwu N. Ojogho
Study: RNs Using MedActionPlan Improved HCAHPS Scores
When staff perceived that patients were not adequately prepared for discharge, they turned to MedActionPlan to provide a medication “calendar” for bedside education.
The result: these nurses achieved a significant improvement in key HCAHPS categories.
Patient Driven Medication Administration in the New Post Renal/Liver Transplant Patient—Starts at Admission
Tia Dechairo RN, Spela Gasperlin RN-BSN, Kristen Hodnik RN-BSN, Karli Lapointe RN-BSN, Ashlee Lohman RN-BSN, Nancy Neal RN-BSN, and Mallory Shull RN-BSN
Study: MedActionPlan Enhances Education and Continuity of Care
In this study, a team from Baylor University Medical Center performing 200 blood and marrow transplants every year details how they used MedActionPlan to significantly improve education and compliance with complex medication regimens.
The study lists key features that made MedActionPlan schedules useful:
- Medication images
- Special medication instructions
- Checklist to record adherence
- Customized for individual patients
- Spanish translations
- HIPAA-compliant security and privacy
- Multiple print formats
The study also found that MedActionPlan improved the continuity of care between inpatient and outpatient settings.
Medactionplan.com as a Tool for Patient Education and Medication Management in the Blood and Marrow Transplant Setting
W. Chuang, M.J. Pineiro, A. Ginsburg, A. Reyes, C. Ueng, C. Matta, M. Taschek, E.A. Agura, R.B. Berryman, L.A. Pineiro, E.A. Vance, J.W. Fay
“MedActionPlan has empowered our patients and their caregivers to be proactive participants in their healthcare program. Patients are able to quickly refer to a centralized and comprehensive medication profile which allows for significantly improved understanding of, and ultimately, compliance with complex medication regimens. MedActionPlan has proved to be a valuable resource and has both enhanced the quality of patient education in our transplant program and improved the continuity of care between inpatient and outpatient settings.”
—Quote from the study
Survey: What Providers Think About MedActionPlan
- 98% saw improvement in patient care and medication adherence when using MedActionPlan. 61.5% rated the improvement as “significant”
- 96% agreed that MedActionPlan improves patients’ understanding of their medication regimens
- 85% said MedActionPlan helps patients better identify their medications
- 89% felt “increased confidence that MAP helps patients feel empowered and contributing to their own care”
Study: MedActionPlan helped decrease medication indication mistakes from 77% to 14%
Medication adherence is particularly challenging for transplant patients. Post transplant, they take a minimum of 10 different medications. The patient needs to understand the purpose and importance of following the instructions for each of those medications.
Emily Feider at Indiana University Health, one of the top 10 transplant centers by volume in the United States, conducted a study to help quantify the effect of MedActionPlan on patients’ ability to accurately report medication instructions and indications.
The study found that using MedActionPlan led to a statistically significant decrease in the number of medication indication mistakes.
The study noted that MedActionPlan clearly presented indications, instructions, and dosing. The study also highlighted some special MedActionPlan formats like insulin sliding scales, Taper/Titration Schedules, the Anticoagulation Action Plan, and Oral Syringe Dosing.
Implementation of a Patient-Education Tool (MedActionPlan™): Effect on the Ability of Renal Transplant Recipients to Accurately Report Medications at First Post-Operative Clinic Visit
Emily Feider, PharmD BCPS
What Patients and Caregivers Think About MedActionPlan and MyMedSchedule
Partner With MedActionPlan Today
We work with healthcare providers, payers, and drug companies to improve outcomes and decrease healthcare costs.